Oct 25, 2022 / 12:00PM GMT
Presentation
Oct 25, 2022 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Harry Kirsch
Novartis AG - CFO
* Samir Shah
Novartis AG - Global Head of IR
* Vasant Narasimhan
Novartis AG - CEO
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emily Field
Barclays Bank PLC, Research Division - Research Analyst
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Florent Cespedes
Societe Generale Cross Asset Research - Senior Equity Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Kerry Ann Holford
Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Mark Douglas Purcell
Novartis AG
(XTER:NOT)
€
134.6
(0%)
Market Cap: 257.94 Bil
Enterprise Value: 293.44 Bil
PE Ratio: 22.33
PB Ratio: 7.84
GF Score: 78/100 Q3 2022 Novartis AG Earnings Presentation Transcript
Oct 25, 2022 / 12:00PM GMT
Release Date Price:
€80.34
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot